ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,740Medicare Part D Prescriptions Filled, Including Refills

Rank: 139 out of 6645

$2.09M Total Retail Price of All Prescriptions

Rank: 74 out of 6645

900 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 900 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 20,148 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$101 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ATELVIA 1,532 1,511 10 1 91
AMLODIPINE BESYLATE 1,056 1,034 2 2
LOSARTAN POTASSIUM 1,025 993 3 12
SIMVASTATIN 690 675 4 1
TRAMADOL HCL 682 654 5 30
OMEPRAZOLE 640 630 6 6
ATORVASTATIN CALCIUM 565 545 7 10
PRAVASTATIN SODIUM 500 479 8 20
TAMSULOSIN HCL 440 434 9 22
METFORMIN HCL 408 372 10 7
LIDOCAINE 385 366 11 325
DIOVAN 376 358 12 19
COMBIVENT 361 360 13 174
SINGULAIR 321 319 14 76
BENICAR 293 283 15 84
ALLOPURINOL 292 277 16 31
CRESTOR 281 266 17 34
ALENDRONATE SODIUM 271 263 18 14
ATENOLOL 270 258 19 8
FAMOTIDINE 259 258 20 33
MONTELUKAST SODIUM 250 241 21 128
TRIAMCINOLONE ACETONIDE 248 236 22 55
NAMENDA 246 242 23 41
LEVOTHYROXINE SODIUM 246 244 23 4
MELOXICAM 241 228 25 46
NEXIUM 239 228 26 40
METOPROLOL TARTRATE 236 230 27 13
HYDROCHLOROTHIAZIDE 232 221 28 9
CARVEDILOL 206 197 29 25
SPIRIVA 200 196 30 65
FLUTICASONE PROPIONATE 188 181 31 26
MICARDIS 183 181 32 232
GLIPIZIDE 182 176 33 23
DONEPEZIL HCL 180 177 34 27
METOPROLOL SUCCINATE 178 174 35 24
LIPITOR 176 173 36 69
FUROSEMIDE 175 173 37 11
NAPHAZOLINE HCL 174 163 38 215
GABAPENTIN 171 166 39 18
ACTOS 163 155 40 71
ADVAIR DISKUS 158 154 41 45
ZOLPIDEM TARTRATE 146 140 42 17
ONGLYZA 139 129 43 168
JANUVIA 138 137 44 38
AVODART 134 130 45 99
ISOSORBIDE MONONITRATE ER 129 128 46 66
QVAR 128 128 47 103
THEOPHYLLINE ANHYDROUS 126 126 48 253
AZITHROMYCIN 125 119 49 44
LOSARTAN-HYDROCHLOROTHIAZIDE 121 120 50 62
DEXILANT 117 117 51 102
PANTOPRAZOLE SODIUM 117 117 51 29
DILTIAZEM ER 107 107 53 182
ZETIA 103 103 54 87
CYMBALTA 102 99 55 78
PIOGLITAZONE HCL 101 93 R 56 184
RIVASTIGMINE 100 100 57 363
ESCITALOPRAM OXALATE 99 95 58 86
NASONEX 98 95 59 126
FLOVENT HFA 96 96 60 293
CLOPIDOGREL 96 96 60 36
CEFUROXIME 95 91 62 317
BENAZEPRIL HCL 84 83 63 21
CITALOPRAM HBR 83 81 64 35
IBANDRONATE SODIUM 80 76 65 147
ACARBOSE 74 67 66 211
EXELON 70 70 67 149
LANSOPRAZOLE 70 67 67 163
MIRTAZAPINE 70 70 67 70
PLAVIX 69 68 70 49
FINASTERIDE 68 68 71 73
VIREAD 63 63 72 259
PREDNISONE 62 62 73 57
HYDROCORTISONE 62 62 73 229
DIGOXIN 61 61 75 59
LISINOPRIL 60 50 76 3
BONIVA 59 57 77 191
LIDODERM 56 56 78 53
ACTONEL 54 53 79 92
CELEBREX 53 53 80 54
WARFARIN SODIUM 53 53 80 16
AGGRENOX 52 52 82 282
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.